Ropeginterferon Alfa-2B

CHEMBL4297819 Phase 4 Disetujui Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
447.5 g/mol
LogP
-1.3
Phase
4

Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon alfa-2b with antiviral and antiproliferative properties, used for the treatment of polycythemia vera and chronic hepatitis C. It acts by binding to cell surface receptors to activate the JAK-STAT signaling pathway, suppressing viral replication and abnormal cell proliferation. Its extended half-life allows for less frequent dosing compared to conventional interferons.

Berat Molekul

447,5000 g/mol

LogP

-1,30

TPSA

136,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

COCCOC(=O)NCCCCC(CCN1CCC[C@H]1C(=O)O)NC(=O)OCCOC

InChI

InChI=1S/C20H37N3O8/c1-28-12-14-30-19(26)21-9-4-3-6-16(22-20(27)31-15-13-29-2)8-11-23-10-5-7-17(23)18(24)25/h16-17H,3-15H2,1-2H3,(H,21,26)(H,22,27)(H,24,25)/t16?,17-/m0/s1

Molecular Formula

C20H37N3O8

HBD / HBA

3 / 9

Ikatan yang Dapat Dirotasi

18

Atom Berat

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon alfa-2b with antiviral and antiproliferative properties, used for the treatment of polycythemia vera and chronic hepatitis C. It acts by binding to cell surface receptors to activate the JAK-STAT signaling pathway, suppressing viral replication and abnormal cell proliferation. Its extended half-life allows for less frequent dosing compared to conventional interferons.

Yes, Ropeginterferon Alfa-2B is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297819. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 86278347. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.